Report Detail
Global and United States Lung Cancer Liquid Biops Market Size, Status and Forecast 2020-2026
- RnM2840309 |
- 28 September, 2020 |
- Global |
- 132 Pages |
- QYResearch |
- Other
Global Lung Cancer Liquid Biops Scope and Market Size
Lung Cancer Liquid Biops market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer Liquid Biops market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Exosomes and RNA
CTCs and ctDNA
Market segment by Application, split into
Hospitals and Clinics
Physicians'office Laboratories
Clinical Diagnostic Laboratories
Based on regional and country-level analysis, the Lung Cancer Liquid Biops market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Lung Cancer Liquid Biops market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Biocept
EntroGen
Cynvenio Biosystems
Exosome Diagnostics
F. Hoffmann-La Roche
Clearbridge BioMedics
Bio-Rad Laboratories
Agena Bioscience
Cancer Genetics
CellMax Life
Nateras
MedGenome
OncoDNA
Genomic Health
Trovagene
Fluxion Biosciences
Biodesix
Epic Sciences
Shuwen Biotech
Personal Genome Diagnostics
Predicine
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Lung Cancer Liquid Biops Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 Exosomes and RNA
- 1.2.3 CTCs and ctDNA
- 1.3 Market by Application
- 1.3.1 Global Lung Cancer Liquid Biops Market Share by Application: 2020 VS 2026
- 1.3.2 Hospitals and Clinics
- 1.3.3 Physicians'office Laboratories
- 1.3.4 Clinical Diagnostic Laboratories
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Lung Cancer Liquid Biops Market Perspective (2015-2026)
- 2.2 Global Lung Cancer Liquid Biops Growth Trends by Regions
- 2.2.1 Lung Cancer Liquid Biops Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Lung Cancer Liquid Biops Historic Market Share by Regions (2015-2020)
- 2.2.3 Lung Cancer Liquid Biops Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Lung Cancer Liquid Biops Players by Market Size
- 3.1.1 Global Top Lung Cancer Liquid Biops Players by Revenue (2015-2020)
- 3.1.2 Global Lung Cancer Liquid Biops Revenue Market Share by Players (2015-2020)
- 3.2 Global Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Lung Cancer Liquid Biops Revenue
- 3.4 Global Lung Cancer Liquid Biops Market Concentration Ratio
- 3.4.1 Global Lung Cancer Liquid Biops Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Liquid Biops Revenue in 2019
- 3.5 Key Players Lung Cancer Liquid Biops Area Served
- 3.6 Key Players Lung Cancer Liquid Biops Product Solution and Service
- 3.7 Date of Enter into Lung Cancer Liquid Biops Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Cancer Liquid Biops Breakdown Data by Type (2015-2026)
- 4.1 Global Lung Cancer Liquid Biops Historic Market Size by Type (2015-2020)
- 4.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Type (2021-2026)
5 Lung Cancer Liquid Biops Breakdown Data by Application (2015-2026)
- 5.1 Global Lung Cancer Liquid Biops Historic Market Size by Application (2015-2020)
- 5.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Lung Cancer Liquid Biops Market Size (2015-2026)
- 6.2 North America Lung Cancer Liquid Biops Market Size by Type (2015-2020)
- 6.3 North America Lung Cancer Liquid Biops Market Size by Application (2015-2020)
- 6.4 North America Lung Cancer Liquid Biops Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe Lung Cancer Liquid Biops Market Size (2015-2026)
- 7.2 Europe Lung Cancer Liquid Biops Market Size by Type (2015-2020)
- 7.3 Europe Lung Cancer Liquid Biops Market Size by Application (2015-2020)
- 7.4 Europe Lung Cancer Liquid Biops Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China Lung Cancer Liquid Biops Market Size (2015-2026)
- 8.2 China Lung Cancer Liquid Biops Market Size by Type (2015-2020)
- 8.3 China Lung Cancer Liquid Biops Market Size by Application (2015-2020)
- 8.4 China Lung Cancer Liquid Biops Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan Lung Cancer Liquid Biops Market Size (2015-2026)
- 9.2 Japan Lung Cancer Liquid Biops Market Size by Type (2015-2020)
- 9.3 Japan Lung Cancer Liquid Biops Market Size by Application (2015-2020)
- 9.4 Japan Lung Cancer Liquid Biops Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia Lung Cancer Liquid Biops Market Size (2015-2026)
- 10.2 Southeast Asia Lung Cancer Liquid Biops Market Size by Type (2015-2020)
- 10.3 Southeast Asia Lung Cancer Liquid Biops Market Size by Application (2015-2020)
- 10.4 Southeast Asia Lung Cancer Liquid Biops Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
- 11.1 Biocept
- 11.1.1 Biocept Company Details
- 11.1.2 Biocept Business Overview
- 11.1.3 Biocept Lung Cancer Liquid Biops Introduction
- 11.1.4 Biocept Revenue in Lung Cancer Liquid Biops Business (2015-2020))
- 11.1.5 Biocept Recent Development
- 11.2 EntroGen
- 11.2.1 EntroGen Company Details
- 11.2.2 EntroGen Business Overview
- 11.2.3 EntroGen Lung Cancer Liquid Biops Introduction
- 11.2.4 EntroGen Revenue in Lung Cancer Liquid Biops Business (2015-2020)
- 11.2.5 EntroGen Recent Development
- 11.3 Cynvenio Biosystems
- 11.3.1 Cynvenio Biosystems Company Details
- 11.3.2 Cynvenio Biosystems Business Overview
- 11.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Introduction
- 11.3.4 Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2015-2020)
- 11.3.5 Cynvenio Biosystems Recent Development
- 11.4 Exosome Diagnostics
- 11.4.1 Exosome Diagnostics Company Details
- 11.4.2 Exosome Diagnostics Business Overview
- 11.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Introduction
- 11.4.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2015-2020)
- 11.4.5 Exosome Diagnostics Recent Development
- 11.5 F. Hoffmann-La Roche
- 11.5.1 F. Hoffmann-La Roche Company Details
- 11.5.2 F. Hoffmann-La Roche Business Overview
- 11.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Introduction
- 11.5.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2015-2020)
- 11.5.5 F. Hoffmann-La Roche Recent Development
- 11.6 Clearbridge BioMedics
- 11.6.1 Clearbridge BioMedics Company Details
- 11.6.2 Clearbridge BioMedics Business Overview
- 11.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Introduction
- 11.6.4 Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2015-2020)
- 11.6.5 Clearbridge BioMedics Recent Development
- 11.7 Bio-Rad Laboratories
- 11.7.1 Bio-Rad Laboratories Company Details
- 11.7.2 Bio-Rad Laboratories Business Overview
- 11.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Introduction
- 11.7.4 Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2015-2020)
- 11.7.5 Bio-Rad Laboratories Recent Development
- 11.8 Agena Bioscience
- 11.8.1 Agena Bioscience Company Details
- 11.8.2 Agena Bioscience Business Overview
- 11.8.3 Agena Bioscience Lung Cancer Liquid Biops Introduction
- 11.8.4 Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2015-2020)
- 11.8.5 Agena Bioscience Recent Development
- 11.9 Cancer Genetics
- 11.9.1 Cancer Genetics Company Details
- 11.9.2 Cancer Genetics Business Overview
- 11.9.3 Cancer Genetics Lung Cancer Liquid Biops Introduction
- 11.9.4 Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2015-2020)
- 11.9.5 Cancer Genetics Recent Development
- 11.10 CellMax Life
- 11.10.1 CellMax Life Company Details
- 11.10.2 CellMax Life Business Overview
- 11.10.3 CellMax Life Lung Cancer Liquid Biops Introduction
- 11.10.4 CellMax Life Revenue in Lung Cancer Liquid Biops Business (2015-2020)
- 11.10.5 CellMax Life Recent Development
- 11.11 Nateras
- 10.11.1 Nateras Company Details
- 10.11.2 Nateras Business Overview
- 10.11.3 Nateras Lung Cancer Liquid Biops Introduction
- 10.11.4 Nateras Revenue in Lung Cancer Liquid Biops Business (2015-2020)
- 10.11.5 Nateras Recent Development
- 11.12 MedGenome
- 10.12.1 MedGenome Company Details
- 10.12.2 MedGenome Business Overview
- 10.12.3 MedGenome Lung Cancer Liquid Biops Introduction
- 10.12.4 MedGenome Revenue in Lung Cancer Liquid Biops Business (2015-2020)
- 10.12.5 MedGenome Recent Development
- 11.13 OncoDNA
- 10.13.1 OncoDNA Company Details
- 10.13.2 OncoDNA Business Overview
- 10.13.3 OncoDNA Lung Cancer Liquid Biops Introduction
- 10.13.4 OncoDNA Revenue in Lung Cancer Liquid Biops Business (2015-2020)
- 10.13.5 OncoDNA Recent Development
- 11.14 Genomic Health
- 10.14.1 Genomic Health Company Details
- 10.14.2 Genomic Health Business Overview
- 10.14.3 Genomic Health Lung Cancer Liquid Biops Introduction
- 10.14.4 Genomic Health Revenue in Lung Cancer Liquid Biops Business (2015-2020)
- 10.14.5 Genomic Health Recent Development
- 11.15 Trovagene
- 10.15.1 Trovagene Company Details
- 10.15.2 Trovagene Business Overview
- 10.15.3 Trovagene Lung Cancer Liquid Biops Introduction
- 10.15.4 Trovagene Revenue in Lung Cancer Liquid Biops Business (2015-2020)
- 10.15.5 Trovagene Recent Development
- 11.16 Fluxion Biosciences
- 10.16.1 Fluxion Biosciences Company Details
- 10.16.2 Fluxion Biosciences Business Overview
- 10.16.3 Fluxion Biosciences Lung Cancer Liquid Biops Introduction
- 10.16.4 Fluxion Biosciences Revenue in Lung Cancer Liquid Biops Business (2015-2020)
- 10.16.5 Fluxion Biosciences Recent Development
- 11.17 Biodesix
- 10.17.1 Biodesix Company Details
- 10.17.2 Biodesix Business Overview
- 10.17.3 Biodesix Lung Cancer Liquid Biops Introduction
- 10.17.4 Biodesix Revenue in Lung Cancer Liquid Biops Business (2015-2020)
- 10.17.5 Biodesix Recent Development
- 11.18 Epic Sciences
- 10.18.1 Epic Sciences Company Details
- 10.18.2 Epic Sciences Business Overview
- 10.18.3 Epic Sciences Lung Cancer Liquid Biops Introduction
- 10.18.4 Epic Sciences Revenue in Lung Cancer Liquid Biops Business (2015-2020)
- 10.18.5 Epic Sciences Recent Development
- 11.19 Shuwen Biotech
- 10.19.1 Shuwen Biotech Company Details
- 10.19.2 Shuwen Biotech Business Overview
- 10.19.3 Shuwen Biotech Lung Cancer Liquid Biops Introduction
- 10.19.4 Shuwen Biotech Revenue in Lung Cancer Liquid Biops Business (2015-2020)
- 10.19.5 Shuwen Biotech Recent Development
- 11.20 Personal Genome Diagnostics
- 10.20.1 Personal Genome Diagnostics Company Details
- 10.20.2 Personal Genome Diagnostics Business Overview
- 10.20.3 Personal Genome Diagnostics Lung Cancer Liquid Biops Introduction
- 10.20.4 Personal Genome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2015-2020)
- 10.20.5 Personal Genome Diagnostics Recent Development
- 11.21 Predicine
- 10.21.1 Predicine Company Details
- 10.21.2 Predicine Business Overview
- 10.21.3 Predicine Lung Cancer Liquid Biops Introduction
- 10.21.4 Predicine Revenue in Lung Cancer Liquid Biops Business (2015-2020)
- 10.21.5 Predicine Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Get latest Market Research Reports on Lung Cancer Liquid Biops . Industry analysis & Market Report on Lung Cancer Liquid Biops is a syndicated market report, published as Global and United States Lung Cancer Liquid Biops Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Lung Cancer Liquid Biops market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
